Question

Please provide, in sentence form, a Balance Sheet and Income Sheet Analysis for CVS & Walgreens. Answer should refelect several paragraphs for each company, so at least one an half for the Income and one and half for the Balance sheet for each company. Please, Please, Please watch syntax and grammar!!

CVS

Balance Sheet

All numbers in thousands

Period Ending	12/31/2017	12/31/2016	12/31/2015
Current Assets
Cash And Cash Equivalents	1,696,000	3,371,000	2,459,000
Short Term Investments	111,000	87,000	88,000
Net Receivables	13,181,000	12,164,000	11,888,000
Inventory	15,296,000	14,760,000	14,001,000
Other Current Assets	945,000	660,000	722,000
Total Current Assets	31,229,000	31,042,000	29,158,000
Long Term Investments	-	-	-
Property Plant and Equipment	10,292,000	10,175,000	9,855,000
Goodwill	38,451,000	38,249,000	38,106,000
Intangible Assets	13,630,000	13,511,000	13,878,000
Accumulated Amortization	-	-	-
Other Assets	1,529,000	1,485,000	1,440,000
Deferred Long Term Asset Charges	-	-	-
Total Assets	95,131,000	94,462,000	92,437,000
Current Liabilities
Accounts Payable	15,472,000	14,883,000	14,319,000
Short/Current Long Term Debt	15,176,000	11,367,000	8,850,000
Other Current Liabilities	-	-	-
Total Current Liabilities	30,648,000	26,250,000	23,169,000
Long Term Debt	22,181,000	25,615,000	26,267,000
Other Liabilities	1,611,000	1,549,000	1,542,000
Deferred Long Term Liability Charges	2,996,000	4,214,000	4,217,000
Minority Interest	4,000	4,000	7,000
Negative Goodwill	-	-	-
Total Liabilities	57,440,000	57,632,000	55,202,000
Stockholders' Equity
Misc. Stocks Options Warrants	-	-	39,000
Redeemable Preferred Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	17,000	17,000	17,000
Retained Earnings	43,556,000	38,983,000	35,506,000
Treasury Stock	-37,765,000	-33,452,000	-28,886,000
Capital Surplus	32,079,000	31,618,000	30,948,000
Other Stockholder Equity	-196,000	-336,000	-389,000
Total Stockholder Equity	37,691,000	36,830,000	37,196,000
Net Tangible Assets	-14,390,000	-14,930,000	-14,788,000

Income Statement

All numbers in thousands

Revenue	12/31/2017	12/31/2016	12/31/2015
Total Revenue	184,765,000	177,526,000	153,290,000
Cost of Revenue	156,220,000	148,669,000	126,762,000
Gross Profit	28,545,000	28,857,000	26,528,000
Operating Expenses
Research Development	-	-	-
Selling General and Administrative	-	-	-
Non Recurring	-	-	-
Others	-	-	-
Total Operating Expenses	-	-	-
Operating Income or Loss	9,517,000	10,366,000	9,475,000
Income from Continuing Operations
Total Other Income/Expenses Net	-208,000	-671,000	-21,000
Earnings Before Interest and Taxes	9,309,000	9,695,000	9,454,000
Interest Expense	1,041,000	1,058,000	838,000
Income Before Tax	8,268,000	8,637,000	8,616,000
Income Tax Expense	1,637,000	3,317,000	3,386,000
Minority Interest	4,000	4,000	7,000
Net Income From Continuing Ops	6,631,000	5,320,000	5,230,000
Non-recurring Events
Discontinued Operations	-8,000	-1,000	9,000
Extraordinary Items	-	-	-
Effect Of Accounting Changes	-	-	-
Other Items	-	-	-
Net Income
Net Income	6,622,000	5,317,000	5,237,000
Preferred Stock And Other Adjustments	-	-	-
Net Income Applicable To Common Shares	6,622,000	5,317,000	5,237,000

Walgreens

Income Statement

All numbers in thousands

Revenue	8/31/2017	8/31/2016	8/31/2015
Total Revenue	118,214,000	117,351,000	103,444,000
Cost of Revenue	89,052,000	87,477,000	76,691,000
Gross Profit	29,162,000	29,874,000	26,753,000
Operating Expenses
Research Development	-	-	-
Selling General and Administrative	23,605,000	23,873,000	22,085,000
Non Recurring	-	-	-
Others	-	-	-
Total Operating Expenses	-	-	-
Operating Income or Loss	5,557,000	6,001,000	4,668,000
Income from Continuing Operations
Total Other Income/Expenses Net	-11,000	-261,000	1,248,000
Earnings Before Interest and Taxes	5,546,000	5,740,000	5,916,000
Interest Expense	693,000	596,000	605,000
Income Before Tax	4,853,000	5,144,000	5,311,000
Income Tax Expense	752,000	953,000	1,032,000
Minority Interest	808,000	401,000	439,000
Net Income From Continuing Ops	4,078,000	4,173,000	4,220,000
Non-recurring Events
Discontinued Operations	-	-	-
Extraordinary Items	-	-	-
Effect Of Accounting Changes	-	-	-
Other Items	-	-	-
Net Income
Net Income	4,078,000	4,173,000	4,220,000
Preferred Stock And Other Adjustments	-	-	-
Net Income Applicable To Common Shares	4,078,000	4,173,000	4,220,000

Balance Sheet

All numbers in thousands

Period Ending	8/31/2017	8/31/2016	8/31/2015
Current Assets
Cash And Cash Equivalents	3,301,000	9,807,000	3,000,000
Short Term Investments	-	-	-
Net Receivables	6,528,000	6,260,000	6,849,000
Inventory	8,899,000	8,956,000	8,678,000
Other Current Assets	1,025,000	860,000	1,130,000
Total Current Assets	19,753,000	25,883,000	19,657,000
Long Term Investments	6,320,000	6,174,000	1,242,000
Property Plant and Equipment	13,642,000	14,335,000	15,068,000
Goodwill	15,632,000	15,527,000	16,372,000
Intangible Assets	10,156,000	10,302,000	12,351,000
Accumulated Amortization	-	-	-
Other Assets	506,000	467,000	4,092,000
Deferred Long Term Asset Charges	-	-	-
Total Assets	66,009,000	72,688,000	68,782,000
Current Liabilities
Accounts Payable	18,296,000	16,690,000	15,489,000
Short/Current Long Term Debt	251,000	323,000	1,068,000
Other Current Liabilities	-	-	-
Total Current Liabilities	18,547,000	17,013,000	16,557,000
Long Term Debt	12,684,000	18,705,000	13,315,000
Other Liabilities	4,223,000	4,045,000	4,072,000
Deferred Long Term Liability Charges	2,281,000	2,644,000	3,538,000
Minority Interest	808,000	401,000	439,000
Negative Goodwill	-	-	-
Total Liabilities	37,735,000	42,407,000	37,482,000
Stockholders' Equity
Misc. Stocks Options Warrants	-	-	-
Redeemable Preferred Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	12,000	12,000	12,000
Retained Earnings	30,137,000	27,684,000	25,089,000
Treasury Stock	-9,971,000	-4,934,000	-3,977,000
Capital Surplus	10,339,000	10,111,000	9,953,000
Other Stockholder Equity	-3,051,000	-2,993,000	-216,000
Total Stockholder Equity	27,466,000	29,880,000	30,861,000
Net Tangible Assets	1,678,000	4,051,000	2,138,000

Answer 1

Analysis of Balance Sheet of CVS
Period Ending Dec 2017. Dec 2016 and Dec 2015		12/31/2017	12/31/2016	12/31/2015
Cash And Cash Equivalents	Decreased in the year ending Dec 2017 and increased in Dec 2016	-16,75,000	9,12,000	2459000
Short Term Investments	Increased in Dec 2017 and Decrased in Dec 2016	24,000	-1,000	88000
Net Receivables	Increased in Dec 2017 and increased in Dec 2016	10,17,000	2,76,000	11888000
Inventory	Increased in Dec 2017 and increased in Dec 2016	5,36,000	7,59,000	14001000
Other Current Assets	Increased in Dec 2017 and Decrased in Dec 2016	2,85,000	-62,000	722000
Total Current Assets	Increased in Dec 2017 and increased in Dec 2016	1,87,000	18,84,000	29158000
Property Plant and Equipment	Increased in Dec 2017 and increased in Dec 2016	1,17,000	3,20,000	9855000
Goodwill	Increased in Dec 2017 and increased in Dec 2016	2,02,000	1,43,000	38106000
Intangible Assets	Increased in Dec 2017 and Decrased in Dec 2016	1,19,000	-3,67,000	13878000
Other Assets	Increased in Dec 2017 and increased in Dec 2016	44,000	45,000	1440000
Total Assets	Increased in Dec 2017 and increased in Dec 2016	6,69,000	20,25,000	92437000
Accounts Payable	Increased in Dec 2017 and increased in Dec 2016	5,89,000	5,64,000	14319000
Short/Current Long Term Debt	Increased in Dec 2017 and increased in Dec 2016	38,09,000	25,17,000	8850000
Total Current Liabilities	Increased in Dec 2017 and increased in Dec 2016	43,98,000	30,81,000	23169000
Long Term Debt	Decreased in the year ending Dec 2017 and Decreased in Dec 2016	-34,34,000	-6,52,000	26267000
Other Liabilities	Increased in Dec 2017 and increased in Dec 2016	62,000	7,000	1542000
Deferred Long Term Liability Charges	Decreased in the year ending Dec 2017 and Decreased in Dec 2016	-12,18,000	-3,000	4217000
Minority Interest	No change In Dec 2107 nad decreased in Dec 2016	0	-3,000	7000
Total Liabilities	Decreased in Dec 2017 and increased in Dec 2016	-1,92,000	24,30,000	55202000
Misc. Stocks Options Warrants	No change In Dec 2107 nad decreased in Dec 2016	0	-39,000	39000
Common Stock		0	0	17000
Retained Earnings	Increased in Dec 2017 and increased in Dec 2016	45,73,000	34,77,000	35506000
Treasury Stock	Decreased in Dec 2017 and Decreased in Dec 2016	-43,13,000	-45,66,000	-28886000
Capital Surplus	Increased in Dec 2017 and increased in Dec 2016	4,61,000	6,70,000	30948000
Other Stockholder Equity	Increased in Dec 2017 and increased in Dec 2016	1,40,000	53,000	-389000
Total Stockholder Equity	Increased in Dec 2017 and Decrased in Dec 2016	8,61,000	-3,66,000	37196000
Net Tangible Assets	Increased in Dec 2017 and Decrased in Dec 2016	5,40,000	-1,42,000	-14788000
Analysis of Income Statement of CVS		0	0	0
All numbers in thousands		0	0	0
Total Revenue	Increased in Dec 2017 and Decrased in Dec 2016	72,39,000	2,42,36,000	153290000
Cost of Revenue	Increased in Dec 2017 and Decrased in Dec 2016	75,51,000	2,19,07,000	126762000
Gross Profit	Decreased in Dec 2017 and increased in Dec 2016	-3,12,000	23,29,000	26528000
Operating Income or Loss	Decreased in Dec 2017 and increased in Dec 2016	-8,49,000	8,91,000	9475000
Total Other Income/Expenses Net	Increased in Dec 2017 and Decrased in Dec 2016	4,63,000	-6,50,000	-21000
Earnings Before Interest and Taxes	Decreased in Dec 2017 and increased in Dec 2016	-3,86,000	2,41,000	9454000
Interest Expense	Decreased in Dec 2017 and increased in Dec 2016	-17,000	2,20,000	838000
Income Before Tax	Decreased in Dec 2017 and increased in Dec 2016	-3,69,000	21,000	8616000
Income Tax Expense	Decreased in Dec 2017 and Decreased in Dec 2016	-16,80,000	-69,000	3386000
Minority Interest	No change In Dec 2107 nad decreased in Dec 2016	0	-3,000	7000
Net Income From Continuing Ops	Increased in Dec 2017 and incrased in Dec 2016	13,11,000	90,000	5230000
Discontinued Operations	Decreased in Dec 2017 and Decreased in Dec 2016	-7,000	-10,000	9000
Net Income	Increased in Dec 2017 and incrased in Dec 2016	13,05,000	80,000	5237000
Net Income Applicable To Common Shares	Increased in Dec 2017 and incrased in Dec 2016	13,05,000	80,000	5237000
Anaysis of Balance Sheet of Walgreens
All numbers in thousands
Period Ending Aug 2017, Aug 2016 and Aug 2015
Current Assets
Cash And Cash Equivalents	Augreased in Aug 2017 and increased in Aug 2016	-65,06,000	68,07,000	30,00,000
Net Receivables	Increased in Aug 2017 and Augreased in Aug 2016	2,68,000	-5,89,000	68,49,000
Inventory	Augreased in Aug 2017 and increased in Aug 2016	-57,000	2,78,000	86,78,000
Other Current Assets	Increased in Aug 2017 and Augreased in Aug 2016	1,65,000	-2,70,000	11,30,000
Total Current Assets	Augreased in Aug 2017 and increased in Aug 2016	-61,30,000	62,26,000	1,96,57,000
Long Term Investments	Increased in Aug 2017 and increased in Aug 2016	1,46,000	49,32,000	12,42,000
Property Plant and Equipment	Augreased in Aug 2017 and Augreased in Aug 2016	-6,93,000	-7,33,000	1,50,68,000
Goodwill	Increased in Aug 2017 and Augreased in Aug 2016	1,05,000	-8,45,000	1,63,72,000
Intangible Assets	Augreased in Aug 2017 and increased in Aug 2016	-1,46,000	-20,49,000	1,23,51,000
Other Assets	Increased in Aug 2017 and Augreased in Aug 2016	39,000	-36,25,000	40,92,000
Total Assets	Augreased in Aug 2017 and increased in Aug 2016	-66,79,000	39,06,000	6,87,82,000
Accounts Payable	Increased in Aug 2017 and increased in Aug 2016	16,06,000	12,01,000	1,54,89,000
Short/Current Long Term Debt	Augreased in Aug 2017 and Augreased in Aug 2016	-72,000	-7,45,000	10,68,000
Total Current Liabilities	Increased in Aug 2017 and increased in Aug 2016	15,34,000	4,56,000	1,65,57,000
Long Term Debt	Augreased in Aug 2017 and increased in Aug 2016	-60,21,000	53,90,000	1,33,15,000
Other Liabilities	Increased in Aug 2017 and Augreased in Aug 2016	1,78,000	-27,000	40,72,000
Deferred Long Term Liability Charges	Augreased in Aug 2017 and Augreased in Aug 2016	-3,63,000	-8,94,000	35,38,000
Minority Interest	Increased in Aug 2017 and Augreased in Aug 2016	4,07,000	-38,000	4,39,000
Total Liabilities	Augrease in Aug 2017 and increased in Aug 2016	-46,72,000	49,25,000	3,74,82,000
Common Stock		0	0	12,000
Retained Earnings	Increased in Aug 2017 and increased in Aug 2016	24,53,000	25,95,000	2,50,89,000
Treasury Stock	Augreased in Aug 2017 and Augreased in Aug 2016	-50,37,000	-9,57,000	-39,77,000
Capital Surplus	Increased in Aug 2017 and increased in Aug 2016	2,28,000	1,58,000	99,53,000
Other Stockholder Equity	Augreased in Aug 2017 and Augreased in Aug 2016	-58,000	-27,77,000	-2,16,000
Total Stockholder Equity	Augreased in Aug 2017 and Augreased in Aug 2016	-24,14,000	-9,81,000	3,08,61,000
Net Tangible Assets	Augrease in Aug 2017 and increased in Aug 2016	-23,73,000	19,13,000	21,38,000
Analysis of Income Statement of Walgreens
All numbers in thousands
Total Revenue	Increased in Aug 2017 and increased in Aug 2016	8,63,000	1,39,07,000	10,34,44,000
Cost of Revenue	Increased in Aug 2017 and increased in Aug 2016	15,75,000	1,07,86,000	7,66,91,000
Gross Profit	Augrease in Aug 2017 and increased in Aug 2016	-7,12,000	31,21,000	2,67,53,000
Selling General and Administrative	Augrease in Aug 2017 and increased in Aug 2016	-2,68,000	17,88,000	2,20,85,000
Operating Income or Loss	Augrease in Aug 2017 and increased in Aug 2016	-4,44,000	13,33,000	46,68,000
Total Other Income/Expenses Net	Increased in Aug 2017 and Augreased in Aug 2016	2,50,000	-15,09,000	12,48,000
Earnings Before Interest and Taxes	Augrease in Aug 2017 and Augreased in Aug 2016	-1,94,000	-1,76,000	59,16,000
Interest Expense	Increased in Aug 2017 and Augreased in Aug 2016	97,000	-9,000	6,05,000
Income Before Tax	Augrease in Aug 2017 and Augreased in Aug 2016	-2,91,000	-1,67,000	53,11,000
Income Tax Expense	Augrease in Aug 2017 and Augreased in Aug 2016	-2,01,000	-79,000	10,32,000
Minority Interest	Increased in Aug 2017 and Augreased in Aug 2016	4,07,000	-38,000	4,39,000
Net Income From Continuing Ops	Augrease in Aug 2017 and Augreased in Aug 2016	-95,000	-47,000	42,20,000
Net Income	Augrease in Aug 2017 and Augreased in Aug 2016	-95,000	-47,000	42,20,000
Net Income Applicable To Common Shares	Augrease in Aug 2017 and Augreased in Aug 2016	-95,000	-47,000	42,20,000